ResearcherNational Cheng Kung UniversityNo recent work listed

Shu-Ling Pen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5080745572. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: Fr… Co-author DOI 10.1016/j.radonc.2021.02.037 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui-Ju Ch'ang · 1 shared paper, 2021 · strength 0.13
- Paper High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curativel… DOI 10.1016/j.radonc.2021.02.037 ↗
Jen‐Shi Chen · 1 shared paper, 2021 · strength 0.13
- Paper High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curativel… DOI 10.1016/j.radonc.2021.02.037 ↗
Wen‐Chi Chou · 1 shared paper, 2021 · strength 0.13
- Paper High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curativel… DOI 10.1016/j.radonc.2021.02.037 ↗
Li‐Tzong Chen · 1 shared paper, 2021 · strength 0.13
- Paper High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curativel… DOI 10.1016/j.radonc.2021.02.037 ↗
Yan‐Shen Shan · 1 shared paper, 2021 · strength 0.13
- Paper High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curativel… DOI 10.1016/j.radonc.2021.02.037 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.